Haemophilus B and hepatitis B vaccine

Haemophilus B and hepatitis B vaccine is a combination vaccine whose generic name is Haemophilus b conjugate and hepatitis B recombinant vaccine.[1] It protects against the infectious diseases Haemophilus influenzae type B and hepatitis B.

Haemophilus B and hepatitis B vaccine
Combination of
Hib vaccineVaccine
Hepatitis B vaccineVaccine
Clinical data
Trade namesComvax
AHFS/Drugs.comMicromedex Detailed Consumer Information
Pregnancy
category
  • US: C (Risk not ruled out)
    Routes of
    administration    		Intramuscular injection
    ATC code
    Identifiers
    ChemSpider
    • none

    A branded formulation, Comvax, was marketed in the USA by Merck.[2][3] It was discontinued in 2014.[4]

    References
    1. "Comvax". Drugs.com. Retrieved 15 July 2018.
    2. "Notice to Readers FDA Approval for Infants of a Haemophilus influenzae Type b Conjugate and Hepatitis B (Recombinant) Combined Vaccine". Morbidity and Mortality Weekly Report. Centers for Disease Control and Prevention. 7 February 1997. pp. 107–109. Retrieved 15 July 2018.
    3. "Comvax package insert" (PDF). Retrieved 15 July 2018.
    4. Zarei, Adi Essam; Almehdar, Hussein A.; Redwan, Elrashdy M. (2016). "Hib Vaccines: Past, Present, and Future Perspectives". Journal of Immunology Research. 2016: 1–18. doi:10.1155/2016/7203587. ISSN 2314-8861. PMC 4745871.
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.